Administration of Mycobacterium leprae rHsp65 aggravates experimental autoimmune uveitis in mice.
about
A Mycobacterium leprae Hsp65 mutant as a candidate for mitigating lupus aggravation in mice.Novel CD28 antagonist mPEG PV1-Fab' mitigates experimental autoimmune uveitis by suppressing CD4+ T lymphocyte activation and IFN-γ production.Mycobacterium leprae Hsp65 administration reduces the lifespan of aged high antibody producer mice.The Role of M. leprae Hsp65 Protein and Peptides in the Pathogenesis of Uveitis.
P2860
Administration of Mycobacterium leprae rHsp65 aggravates experimental autoimmune uveitis in mice.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Administration of Mycobacteriu ...... al autoimmune uveitis in mice.
@ast
Administration of Mycobacteriu ...... al autoimmune uveitis in mice.
@en
type
label
Administration of Mycobacteriu ...... al autoimmune uveitis in mice.
@ast
Administration of Mycobacteriu ...... al autoimmune uveitis in mice.
@en
prefLabel
Administration of Mycobacteriu ...... al autoimmune uveitis in mice.
@ast
Administration of Mycobacteriu ...... al autoimmune uveitis in mice.
@en
P2093
P2860
P1433
P1476
Administration of Mycobacteriu ...... tal autoimmune uveitis in mice
@en
P2093
Alessandra Gonçalves Commodaro
Eliana B Marengo
Fernanda C V Portaro
Jean Pierre S Peron
Luiz Vicente Rizzo
Osvaldo Augusto Sant'Anna
P2860
P356
10.1371/JOURNAL.PONE.0007912
P407
P577
2009-11-19T00:00:00Z